Endocrine Disruptors: Navigating the Regulatory Maze


Thursday, June 4, 2020
11:00 AM -12:00 PM EDT (5:00 PM - 6:00 PM CEST)


Online Webinar
stack of white and colored documents isolated on a white background


How well do you know the regulatory requirements regarding the assessment of endocrine disrupting potential of active substances? In this webinar, the first of a three-part series, regulatory consultant Ira Koval will explain updates to PPP Regulation (Regulation (EC) 1107/2009) and BPR (Regulation (EU) 528/2012).

Bring your questions and prepare to learn something new as we dive into templates, data requirements, the evaluation of co-formulants, and assessing the impact on non-target organisms. We will also share insights into other relevant issues, such as investigation of the mode of action, when and which new data are expected to be generated and whether the opportunities exist to demonstrate negligible exposure.


Webinar Presenter

Ira Koval Headshot

Ira Koval, PhD
Section Head of Global Regulatory Consultancy
Charles River


View the other webinars in the series:

Have a scheduling conflict? Sign up even if you can't make it; we'll share the recording after.


During this time of uncertainty, we are focused on providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.